Neuropsychological and Genetic Factors in Alzheimer's Disease
This paper examines the neuropsychological and genetic factors surrounding Alzheimer's disease, one of the most prevalent forms of dementia worldwide. Beginning with a brief history of the disease's discovery by Alois Alzheimer, the paper explores the genetic underpinnings of both early-onset and late-onset forms, including the roles of amyloid precursor protein mutations and the APOE ε4 allele. It then addresses neuropsychological factors, particularly the concept of cognitive reserve and its influence on disease progression. The paper also outlines the early signs of Alzheimer's disease and reviews current pharmacological and non-pharmacological treatment modalities aimed at improving recall and slowing cognitive decline.
- Introduction: Overview of Alzheimer's disease and paper scope
- Brief History of Alzheimer's Disease: Discovery by Alois Alzheimer and global prevalence
- Genetic Factors Surrounding Alzheimer's Disease: Genes, mutations, and early- vs. late-onset types
- Neuropsychological Factors Surrounding Alzheimer's Disease: Cognitive reserve and its role in disease risk
- Early Signs of Alzheimer's Disease: Memory impairment and imagination inflation symptoms
- Modalities to Improve Recall: Pharmacological and non-pharmacological treatment options
- Conclusion: Summary of disease types, causes, and treatments
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper integrates multiple disciplinary perspectives — genetic, neuropsychological, and clinical — giving readers a comprehensive overview of Alzheimer's disease rather than a narrowly focused account.
- It distinguishes clearly between early-onset and late-onset Alzheimer's disease, explaining the distinct genetic mechanisms behind each type with specific chromosome and gene references.
- The section on cognitive reserve is well-developed, connecting theoretical concepts to real-world epidemiological findings and practical implications for aging populations.
Key academic technique demonstrated
The paper demonstrates effective synthesis of multiple peer-reviewed sources to build a coherent, multi-factor explanation of a complex disease. Rather than presenting each source in isolation, the author weaves together findings on genetics, neuroscience, and psychology to support an integrated argument about the causes, progression, and treatment of Alzheimer's disease.
Structure breakdown
The paper follows a logical progression: an introductory framing section is followed by a historical overview, two core analytical sections (genetic and neuropsychological factors), a section on early symptoms, a section on treatment modalities, and a concise conclusion. This structure moves from background context to causal analysis to clinical application, mirroring the structure common in health sciences literature reviews.
Introduction
Alzheimer's disease is a debilitating illness that interferes with an individual's ability to recall both short-term and long-term memory. People diagnosed with the disease can initially recall recent activities, though they have difficulties with long-term memory. However, as the disease develops over time, patients experience difficulties with both short- and long-term memory. Given the increase in the number of people diagnosed with this condition, Alzheimer's disease is regarded as the most common type of dementia among the elderly. This clinical condition is caused by neurodegeneration and is characterized by a progressive decline in mental ability as well as difficulties in independent living. This paper examines the neuropsychological and genetic factors surrounding the illness, the early signs of the disease, and possible approaches to treatment.
Brief History of Alzheimer's Disease
Alzheimer's disease has a history that can be traced back over 100 years, to when Alois Alzheimer, a German physician, conducted a postmortem analysis of one of his patients' dementia-ravaged brains. When conducting this analysis, Alzheimer hoped to expose the biological roots of the patient's rapid and severe mental deterioration and unusual mood swings (Marsa, 2015, p. 54). The patient was surrounded by a fog of confusion, displayed delusional behavior, and would occasionally become wild and uncontrollable. During the examination, Alzheimer noticed that small clumps of hard bundles of protein — known as amyloid plaques — were clustered next to the labyrinthine circuitry of healthy nerve cells. Moreover, many fibers extending from the healthy nerve cells were not only tangled but also thickened. The main characteristic features of Alzheimer's disease are therefore these amyloid plaques and tau tangles in the brain circuitry. Since then, scientists and physicians have focused on identifying how these proteins function and what role they play in aberrant brain circuitry.
Since its discovery, Alzheimer's disease has become a major public health issue and is considered one of the most common forms of dementia across the globe, as it is a progressive neurodegenerative disease that affects many people, especially the elderly. The disease affects more than 20% of people aged 80 years and above and is estimated to affect more than 35 million people worldwide by 2050 (Femminella, Ferrara & Rengo, 2015, p. 1). As a result of this projection, Alzheimer's disease is increasingly likely to generate a significant economic and social burden.
References
"Alzheimer's Disease Genetics Fact Sheet." (2015, July 20). Alzheimer's Disease Education and Referral Center. Retrieved from National Institute on Aging — U.S. Department of Health and Human Services website: https://www.nia.nih.gov/alzheimers/publication/alzheimers-disease-genetics-fact-sheet
Bertram, L. & Tanzi, R. E. (2012). The genetics of Alzheimer's disease. In D. Teplow (Ed.), Progress in molecular biology and translational science (Chap. 3, pp. 79–100).
Femminella, G. D., Ferrara, N. & Rengo, G. (2015, February 12). The emerging role of microRNAs in Alzheimer's disease. Frontiers in Psychology, 6(40), 1–5.
Huang et al. (2015, July). Neurorestorative strategies for Alzheimer's disease. Neurology India, 63(4), 583–588.
Levy-Lahad, E. & Bird, T. D. (1996, November). Genetic factors in Alzheimer's disease: A review of recent advances. Annals of Neurology, 40(6), 829–840.
Marsa, L. (2015, March). Cracking the Alzheimer's code. Discover, 36(2), 54–61.
O'Connor et al. (2015, July). The imagination inflation effect in healthy older adults and patients with mild Alzheimer's disease. Neuropsychology, 29(4), 550–560.
Sobral, M., Pestana, M. H. & Paul, C. (2015, January 24). Cognitive reserve and the severity of Alzheimer's disease. Arq Neuropsiquiatr, 73(6), 480–486.
Sobral, M., Pestana, M. H. & Paul, C. (2015). The impact of cognitive reserve in neuropsychological and functional abilities of Alzheimer's disease patients. Psychology & Neuroscience, 8(1), 39–55.
Tucker, A. M. & Stern, Y. (2011, June 1). Cognitive reserve in aging. Current Alzheimer's Research, 8(4), 354–360.
Create your account
Always verify citation format against your institution’s current style guide requirements.